contract_awardAwarded Monday, July 20, 2026Analyzed

HUMAN SERVICES, NEW JERSEY DEPARTMENT OF: $209M Department of Health and Human Services Grant

Neutral

Summary

This $209M federal grant to New Jersey's Department of Human Services for opioid response is a state-level initiative with no direct public company beneficiary. It signals continued government commitment to addiction treatment but does not directly affect publicly traded entities.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.This is a state government grant with no direct public company recipient.
  • 2.Sustained federal funding for opioid response supports the broader healthcare sector, particularly addiction treatment services.
  • 3.No specific tickers are tied to this contract; investors should avoid speculative mapping.

Market Implications

Since the recipient is a state government, this contract does not create direct revenue for any publicly traded company. The broader trend of federal opioid response funding may benefit sub-sectors like medication-assisted treatment providers and harm reduction products, but no individual stock is materially impacted by this award.

Full Analysis

The $209M award from SAMHSA to the New Jersey Department of Human Services is a multi-year grant (2024-2027) to expand opioid and stimulant use disorder services. The recipient is a state government agency, not a publicly traded company, so there is no direct stock impact. The contract funds medications for opioid use disorder, harm reduction, prevention, recovery support, and new initiatives like integrated care and public education campaigns. While companies in the addiction treatment space (e.g., Indivior, Opiant, Alkermes) may indirectly benefit from increased service utilization, no specific contract relationship exists. Related legislative signals in the HillSignal database do not directly connect to this grant, as they focus on unrelated areas like inhalant prevention, watershed projects, and immigration. Investors should watch for future appropriations bills that fund SAMHSA grants, which could signal sustained spending on behavioral health.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Contract Details

Recipient

HUMAN SERVICES, NEW JERSEY DEPARTMENT OF

Award Amount

$209,457,258

Awarding Agency

Department of Health and Human Services

Sub-Agency

Substance Abuse and Mental Health Services Administration

Contract Type

PROJECT GRANT (B)

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →